Skip to content
Menu

Dare Bioscience Q3 EPS $(0.18) Beats $(0.26) Estimate, Sales $47.628K Miss $2.018M Estimate

Benzinga Newsdesk 1 day ago

NewsEarningsEarnings BeatsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.26) by 30.77 percent. This is a 35.71 percent increase over losses of $(0.28) per share from

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.26) by 30.77 percent. This is a 35.71 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $47.628 thousand which missed the analyst consensus estimate of $2.018 million by 97.64 percent. This is a 2.01K percent increase over sales of $2.262 thousand the same period last year.

Read at benzinga.com